Vaporizing Chest Rub 4 Oz.

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for the temporary relief of cough due to minor throat and bronchial irritation associated with a cold. Additionally, it is indicated for the temporary relief of minor aches and pains of muscles and joints.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For cough suppression, a thick layer of the product should be applied to the chest and throat. If desired, the area may be covered with a warm, dry cloth to enhance the effect. It is recommended to keep clothing loose around the throat and chest to facilitate the inhalation of vapors. This application may be performed up to three times daily or as directed by a healthcare professional.

For the relief of minor aches and pains in muscles and joints, the product should be applied to the affected areas. This application should not exceed three to four times daily.

The product is intended for topical application only. It is important to note that the use of this product is not recommended for children under the age of two years.

Contraindications

There are no contraindications listed for this product. However, it is imperative to seek medical assistance or contact a Poison Control Center immediately if the product is swallowed.

Warnings and Precautions

For external use only; contact with eyes should be avoided. This product is contraindicated for oral ingestion, application in the nostrils, use on wounds or damaged skin, and should not be used in conjunction with tight bandages.

Healthcare professionals should advise patients to consult a physician prior to use if they have a cough accompanied by excessive phlegm (mucus) or if the cough is associated with chronic conditions such as smoking, asthma, or emphysema.

During the application of this product, it is imperative to avoid heating, microwaving, or adding it to hot water or any container that may contain heated water, as this may lead to spattering and potential burns.

Patients should be instructed to discontinue use and seek medical advice if muscle aches and pains persist for more than 7 days or if they recur. Additionally, if a cough lasts longer than 7 days, returns, or is accompanied by fever, rash, or a persistent headache, it is essential to consult a healthcare provider, as these symptoms may indicate a serious underlying condition.

In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Side Effects

Patients using this product should be aware of several important warnings and precautions. This product is intended for external use only and should not come into contact with the eyes. It is contraindicated for oral ingestion, application in the nostrils, use on wounds or damaged skin, and should not be used in conjunction with tight bandages.

Before using this product, patients are advised to consult a healthcare professional if they have a cough accompanied by excessive phlegm, or if they experience a cough associated with chronic conditions such as smoking, asthma, or emphysema.

While using this product, patients should avoid heating, microwaving, or adding it to hot water or any container that may heat water, as this may lead to spattering and potential burns.

Patients should discontinue use and seek medical advice if muscle aches and pains persist for more than 7 days or if they recur. Additionally, if a cough lasts more than 7 days, returns, or is accompanied by fever, rash, or a persistent headache, these symptoms may indicate a serious underlying condition that requires medical evaluation.

Drug Interactions

No specific drug interactions have been identified for this medication. Additionally, there are no reported interactions with laboratory tests. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Vaporizing Chest Rub 4 Oz. (camphor, eucalyptus oil, menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should not use this product. For children aged 2 years and older, the product can be used for cough suppression by applying a thick layer to the chest and throat, which may be covered with a warm, dry cloth if desired. This application can be repeated up to three times daily or as directed by a healthcare professional. Additionally, for the relief of minor aches and pains in muscles and joints, the product may be applied to the affected areas no more than three to four times daily.

It is crucial to keep this product out of reach of children. In the event of accidental ingestion, medical assistance should be sought immediately, or contact a Poison Control Center.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no information available regarding the use of Vaporizing Chest Rub during pregnancy, including safety concerns, dosage modifications, or any special precautions. Healthcare professionals should exercise caution when recommending this product to pregnant patients due to the lack of data on potential risks or fetal impacts. It is advisable to consider alternative therapies that have established safety profiles in pregnant women.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there are no statements concerning the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved and the individual patient's response. Common symptoms of overdose may include, but are not limited to, altered mental status, cardiovascular instability, respiratory distress, and gastrointestinal disturbances.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and ensuring adequate circulation. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and is deemed appropriate based on clinical judgment.

Furthermore, it is crucial to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable. Continuous monitoring and supportive care remain the cornerstone of managing overdose situations until the patient stabilizes or further interventions are deemed necessary.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Postmarketing experience has identified the following adverse reactions reported voluntarily or through surveillance programs: skin irritation, allergic reactions, and respiratory distress. These events have been documented in the context of routine pharmacovigilance activities.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact a Poison Control Center immediately. This guidance is crucial for ensuring patient safety and minimizing potential risks associated with accidental exposure.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature to maintain its integrity. The container must be kept tightly closed to protect the contents from light exposure, which can compromise the product's efficacy. Additionally, it is important to discard the product after opening to ensure safety and effectiveness.

Additional Clinical Information

The product is administered topically, with specific instructions for different uses. For cough suppression, patients should apply a thick layer to the chest and throat, optionally covering it with a warm, dry cloth to enhance vapor delivery to the nose and mouth. This application can be repeated up to three times daily or as directed by a healthcare professional. For relief of minor aches and pains in muscles and joints, the product should be applied to the affected areas no more than three to four times daily.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Vaporizing Chest Rub 4 Oz., including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)